Search

Your search keyword '"Pike, Andy"' showing total 475 results

Search Constraints

Start Over You searched for: Author "Pike, Andy" Remove constraint Author: "Pike, Andy"
475 results on '"Pike, Andy"'

Search Results

1. 'Left Behind' neighbourhoods in England: Where they are and why they matter.

3. Data from Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1

4. Supplementary Data 1 from Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1

22. 'Left behind places': a geographical etymology.

23. 'Beyond GDP' in cities: Assessing alternative approaches to urban economic development.

24. Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1

25. Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand

28. The Local Nexus Network: Exploring the Future of Localised Food Systems and Associated Energy and Water Supply

30. Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders

31. Supplementary Figure from Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

32. Supplementary Data from Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

34. O-69 - Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand

36. The Role of Intramolecular Reactions and Chemical Degradation in the Apparent Biotransformation Pathways of a Series of SYK Inhibitors

40. ‘Left behind places’: a geographical etymology

41. Optimization of a Series of Novel, Potent and Selective Macrocyclic SYK Inhibitors

42. Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors

46. DDDR-01. AZD9574 IS A NOVEL, BRAIN PENETRANT PARP-1 SELECTIVE INHIBITOR WITH ACTIVITY IN AN INTRACRANIAL XENOGRAFT MODEL OF TRIPLE NEGATIVE BREAST CARCINOMA WITH HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY

47. Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF‐06372865

50. Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

Catalog

Books, media, physical & digital resources